Effect of luteal-phase support on endometrial L-selectin ligand expression after recombinant follicle-stimulating hormone and ganirelix acetate for in vitro fertilization

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 10, 2006, Pages 4043-4049

  Vlahos, Nikos F ^a,e   Lipari, Christopher W ^a   Bankowski, Brandon ^a   Lai, Tsung Hsuan ^a,c,d   King, Jeremy A ^a   Shih, Ie Ming ^a   Fragakis, Konstantine ^b   Zhao, Yulian ^a,f  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c CATHAY GENERAL HOSPITAL   (Taiwan)

^d FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^e UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^f NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; GANIRELIX; L SELECTIN; PROGESTERONE; RECOMBINANT FOLLITROPIN; SEX HORMONE;

ARTICLE; CONTROLLED STUDY; CORPUS LUTEUM; DONOR; FERTILIZATION IN VITRO; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; LUTEAL PHASE; PRIORITY JOURNAL; STAINING;

EID: 33749638777     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-0520     Document Type: Article

References (40)

1. Navot D, Anderson TL, Droesch K, Scott RT, Kreiner D, Rosenwaks Z 1989 Hormonal manipulation of endometrial maturation. J Clin Endocrinol Metab 68:801-807
2. Ringler GE, Strauss 3rd JF 1990 Recent advances in understanding the process of implantation. Curr Opin Obstet Gynecol 2:703-708
3. Cavagna M, Mantese JC 2003 Biomarkers of endometrial receptivity: a review. Placenta 24(Suppl B):S39-S47
4. Noyes RW, Hertig AT, Rock J 1975 Dating the endometrial biopsy. Am J Obstet Gynecol 122:262-263
5. Coutifaris C, Myers ER, Guzick DS, Diamond MP, Carson SA, Legro RS, McGovern PG, Schlaff WD, Carr BR, Steinkampf MP, Silva S, Vogel DL, Leppert PC 2004 Histological dating of timed endometrial biopsy tissue is not related to fertility status. Fertil Steril 82:1264-1272
6. Lessey BA, Castelbaum AJ, Wolf L, Greene W, Paulson M, Meyer WR, Fritz MA 2000 Use of integrins to date the endometrium. Fertil Steril 73:779-787
7. Lessey BA, Castelbaum AJ, Sawin SW, Sun J 1995 Integrins as markers of uterine receptivity in women with primary unexplained infertility. Fertil Steril 63:535-542
8. Bell SC, Keyte JW 1988 N-terminal amino acid sequence of human pregnancy-associated endometrial α1-globulin, an endometrial insulin-like growth factor (IGF) binding protein: evidence for two small molecular weight IGF binding proteins. Endocrinology 123:1202-1204
9. Genbacev OD, Prakobphol A, Foulk RA, Krtolica AR, Ilic D, Singer MS, Yang ZQ, Kiessling LL, Rosen SD, Fisher SJ 2003 Trophoblast L-selectin-mediated adhesion at the maternal-fetal interface. Science 299:405-408
10. Gowans JL, Knight EJ 1964 The route of re-circulation of lymphocytes in the rat. Proc R Soc Lond B Biol Sci 159:257-282
11. Lasky LA 1995 Selectin-carbohydrate interactions and the initiation of the inflammatory response. Annu Rev Biochem 64:113-139
12. Streeter PR, Rouse BT, Butcher EC 1988 Immunohistologic and functional characterization of a vascular addressin involved in lymphocyte homing into peripheral lymph nodes. J Cell Biol 107:1853-1862
13. von Andrian UH 1996 Intravital microscopy of the peripheral lymph node microcirculation in mice. Microcirculation 3:287-300
14. Hemmerich S, Butcher EC, Rosen SD 1994 Sulfation-dependent recognition of high endothelial venules (HEV)-ligands by L-selectin and MECA 79, and adhesion-blocking monoclonal antibody. J Exp Med 180:2219-2226
15. Lai TH, Shih Ie M, Vlahos N, Ho CL, Wallach E, Zhao Y 2005 Differential expression of L-selectin ligand in the endometrium during the menstrual cycle. Fertil Steril 83(Suppl 4):1297-1302
16. ASRM 2002 Guidelines for oocyte donation. Fertil Steril 77:S6-S8
17. Mitsuoka C, Sawada-Kasugai M, Ando-Furui K, Izawa M, Nakanishi H, Nakamura S, Ishida H, Kiso M, Kannagi R 1998 Identification of a major carbohydrate capping group of the L-selectin ligand on high endothelial venules in human lymph nodes as 6-sulfo sialyl Lewis X. J Biol Chem 273:11225-11233
18. King R, Weilbaecher KN, McGill G, Cooley E, Mihm M, Fisher DE 1999 Microphthalmia transcription factor. A sensitive and specific melanocyte marker for melanoma diagnosis. Am J Pathol 155:731-738
19. Murray MJ, Zhang J, Lessey BA 1999 Expression of α6 and β4 integrin subunits throughout the menstrual cycle: no correlation with uterine receptivity. Fertil Steril 72:522-526
20. Budwit-Novotny DA, McCarty KS, Cox EB, Soper JT, Mutch DG, Creasman WT 1986 Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody. Cancer Res 46:5419-5425
21. Edwards RG, Steptoe PC, Purdy JM 1980 Establishing full-term human pregnancies using cleaving embryos grown in vitro. Br J Obstet Gynaecol 87:737-756
22. Tan SL, Maconochie N, Doyle P, Campbell S, Balen A, Bekir J, Brinsden P, Edwards RG, Jacobs HS 1994 Cumulative conception and live-birth rates after in vitro fertilization with and without the use of long, short, and ultrashort regimens of the gonadotropin-releasing hormone agonist buserelin. Am J Obstet Gynecol 171:513-520
23. Benadiva CA, Metzger DA 1994 Superovulation with human menopausal gonadotropins is associated with endometrial gland-stroma dyssynchrony. Fertil Steril 61:700-704
24. Smitz J, Erard P, Camus M, Devroey P, Tournaye H, Wisanto A, Van Steirteghem AC 1992 Pituitary gonadotrophin secretory capacity during the luteal phase in superovulation using GnRH-agonists and HMG in a desensitization or flare-up protocol. Hum Reprod 7:1225-1229
25. Beckers NG, Laven JS, Eijkemans MJ, Fauser BC 2000 Follicular and luteal phase characteristics following early cessation of gonadotrophin-releasing hormone agonist during ovarian stimulation for in-vitro fertilization. Hum Reprod 15:43-49
26. Soliman S, Daya S, Collins J, Hughes EG 1994 The role of luteal phase support in infertility treatment: a meta-analysis of randomized trials. Fertil Steril 61:1068-1076
27. Olivennes F, Fanchin R, Bouchard P, de Ziegler D, Taieb J, Selva J, Frydman R 1994 The single or dual administration of the gonadotropin-releasing hormone antagonist cetrorelix in an in vitro fertilization-embryo transfer program. Fertil Steril 62:468-476
28. Behre HM, Klein B, Steinmeyer E, McGregor GP, Voigt K, Nieschlag E 1992 Effective suppression of luteinizing hormone and testosterone by single doses of the new gonadotropin-releasing hormone antagonist cetrorelix (SB-75) in normal men. J Clin Endocrinol Metab 75:393-398
29. Rabinovici J, Rothman P, Monroe SE, Nerenberg C, Jaffe RB 1992 Endocrine effects and pharmacokinetic characteristics of a potent new gonadotropin- releasing hormone antagonist (ganirelix) with minimal histamine-releasing properties: studies in postmenopausal women. J Clin Endocrinol Metab 75:1220-1225
30. Fattinger KE, Verotta D, Porchet HC, Munafo A, Le Cotonnec JY, Sheiner LB 1996 Modeling a bivariate control system: LH and testosterone response to the GnRH antagonist antide. Am J Physiol 271:E775-E787
31. Oberye JJ, Mannaerts BM, Huisman JA, Timmer CJ 1999 Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon/Orgalutran). Part II. Dose-proportionality and gonadotropin suppression after multiple doses of ganirelix in healthy female volunteers. Fertil Steril 72:1006-1012
32. Olivennes F, Fanchin R, Bouchard P, Taieb J, Selva J, Frydman R 1995 Scheduled administration of a gonadotrophin-releasing hormone antagonist (cetrorelix) on day 8 of in-vitro fertilization cycles: a pilot study. Hum Reprod 10:1382-1386
33. Albano C, Smitz J, Camus M, Riethmuller-Winzen H, Van Steirteghem A, Devroey P 1997 Comparison of different doses of gonadotropin-releasing hormone antagonist cetrorelix during controlled ovarian hyperstimulation. Fertil Steril 67:917-922
34. Beckers NG, Macklon NS, Eijkemans MJ, Ludwig M, Felberbaum RE, Diedrich K, Bustion S, Loumaye E, Fauser BC 2003 Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment. J Clin Endocrinol Metab 88:4186-4192
35. Albano C, Grimbizis G, Smitz J, Riethmuller-Winzen H, Reissmann T, Van Steirteghem A, Devroey P 1998 The luteal phase of nonsupplemented cycles after ovarian superovulation with human menopausal gonadotropin and the gonadotropin-releasing hormone antagonist Cetrorelix. Fertil Steril 70:357-359
36. Albano C, Smitz J, Tournaye H, Riethmuller-Winzen H, Van Steirteghem A, Devroey P 1999 Luteal phase and clinical outcome after human menopausal gonadotrophin/gonadotrophin releasing hormone antagonist treatment for ovarian stimulation in in-vitro fertilization/intracytoplasmic sperm injection cycles. Hum Reprod 14:1426-1430
37. Posaci C, Smitz J, Camus M, Osmanagaoglu K, Devroey P 2000 Progesterone for the luteal support of assisted reproductive technologies: clinical options. Hum Reprod 15(Suppl 1):129-148
38. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP 1998 Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4:844-847
39. Pritts EA, Atwood AK 2002 Luteal phase support in infertility treatment: a meta-analysis of the randomized trials. Hum Reprod 17:2287-2299
40. Lai TH, Zhao Y, Shih Ie M, Ho CL, Bankowski B, Vlahos N 2006 Expression of L-selectin ligands in human endometrium during the implantation window after controlled ovarian stimulation for oocyte donation. Fertil Steril 85:761-763